Literature DB >> 21884340

Diagnostic criteria of acute liver failure: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan.

Satoshi Mochida1, Yasuhiro Takikawa, Nobuaki Nakayama, Makoto Oketani, Takafumi Naiki, Yoshiyuki Yamagishi, Takafumi Ichida, Hirohito Tsubouchi.   

Abstract

The diagnostic criteria of fulminant hepatitis in Japan are different from those of acute liver failure in Europe and the United States, both in regard to the histological features in the liver and the cutoff values of the prothrombin time. Thus, the Intractable Hepato-Biliary Disease Study Group established novel diagnostic criteria for "acute liver failure" in Japan based on the demographic and clinical features of the patients. Patients showing prothrombin time values of 40% or less of the standardized values or international normalized ratios of 1.5 or more caused by severe liver damage within 8 weeks of onset of the symptoms are diagnosed as having "acute liver failure", where the liver function prior to the current onset of liver damage is estimated to be normal. Acute liver failure is classified into "acute liver failure without hepatic coma" and "acute liver failure with hepatic coma," depending on the severity of the hepatic encephalopathy; the latter is further classified into two types, the "acute type" and the "subacute type", in which grade II or more severe hepatic coma develops within 10 days and between 11 and 56 days, respectively, after the onset of disease symptoms. Patients without histological findings of hepatitis, such as those with liver damage caused by drug toxicity, circulatory disturbance or metabolic disease, are also included in the disease entity of "acute liver failure", while acute-on-chronic liver injuries, such as liver injury caused by alcohol, are excluded. A nationwide survey of "acute liver failure" in Japan based on the novel criteria is proposed.
© 2011 The Japan Society of Hepatology.

Entities:  

Year:  2011        PMID: 21884340     DOI: 10.1111/j.1872-034X.2011.00860.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  20 in total

1.  A case of fulminant liver failure associated with hepatitis C virus.

Authors:  Hiromitsu Kanzaki; Akinobu Takaki; Takahito Yagi; Fusao Ikeda; Tetsuya Yasunaka; Kazuko Koike; Yasuhiro Miyake; Yoshiaki Iwasaki; Kazuhiro Nouso; Hiroshi Sadamori; Susumu Shinoura; Yuzo Umeda; Ryuichi Yoshida; Masashi Utusmi; Toshiyoshi Fujiwara; Kazuhide Yamamoto
Journal:  Clin J Gastroenterol       Date:  2014-01-18

2.  Liver Function, Quantified by LiMAx Test, After Major Abdominal Surgery. Comparison Between Open and Laparoscopic Approach.

Authors:  Magnus Kaffarnik; Gabriel Stoeger; Julia Liebich; Christian Grieser; Johann Pratschke; Martin Stockmann
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

3.  Nationwide survey for acute liver failure and late-onset hepatic failure in Japan.

Authors:  Masamitsu Nakao; Nobuaki Nakayama; Yoshihito Uchida; Tomoaki Tomiya; Akio Ido; Isao Sakaida; Osamu Yokosuka; Yasuhiro Takikawa; Kazuaki Inoue; Takuya Genda; Masahito Shimizu; Shuji Terai; Hirohito Tsubouchi; Hajime Takikawa; Satoshi Mochida
Journal:  J Gastroenterol       Date:  2017-10-13       Impact factor: 7.527

4.  The recovery of the PT-INR to less than 1.3 predicts survival in patients with severe acute liver injury.

Authors:  Seiichi Mawatari; Akihiro Moriuchi; Fuminori Ohba; Tetsu Kawano; Kohei Oda; Yasuhiro Takikawa; Hajime Takikawa; Akio Ido; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2017-12-19       Impact factor: 7.527

5.  Successful living donor liver transplantation for acute liver failure after acetylsalicylic acid overdose.

Authors:  Tomoki Shirota; Toshihiko Ikegami; Satoshi Sugiyama; Kouji Kubota; Akira Shimizu; Yasunari Ohno; Atsuyoshi Mita; Koichi Urata; Yuichi Nakazawa; Akira Kobayashi; Mai Iwaya; Shinichi Miyagawa
Journal:  Clin J Gastroenterol       Date:  2015-02-25

Review 6.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

7.  Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies.

Authors:  Satoshi Mochida; Masamitsu Nakao; Nobuaki Nakayama; Yoshihito Uchida; Sumiko Nagoshi; Akio Ido; Toshihide Mimura; Masayoshi Harigai; Hiroshi Kaneko; Hiroko Kobayashi; Tetsuya Tsuchida; Hiromichi Suzuki; Nobuyuki Ura; Yuichi Nakamura; Masami Bessho; Kazuo Dan; Shigeru Kusumoto; Yasutsuna Sasaki; Hirofumi Fujii; Fumitaka Suzuki; Kenji Ikeda; Kazuhiko Yamamoto; Hajime Takikawa; Hirohito Tsubouchi; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2016-02-01       Impact factor: 7.527

8.  Acute liver disease in Japan: a nationwide analysis of the Japanese Diagnosis Procedure Combination database.

Authors:  Masaya Sato; Ryosuke Tateishi; Hideo Yasunaga; Hiromasa Horiguchi; Haruhiko Yoshida; Shinya Matsuda; Kiyohide Fushimi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2013-06-20       Impact factor: 7.527

9.  Acute pancreatitis and multiple organ failure-Who beats the odds?

Authors:  Felix Nickel; Philipp Anthony Wise
Journal:  United European Gastroenterol J       Date:  2021-03       Impact factor: 4.623

Review 10.  Acute liver failure in Japan: definition, classification, and prediction of the outcome.

Authors:  Kayoko Sugawara; Nobuaki Nakayama; Satoshi Mochida
Journal:  J Gastroenterol       Date:  2012-07-24       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.